FTK 8-K
Flotek Industries Inc/Cn/ (FTK)
8-K
2026-09-09
For: 2026-09-09
View Original
Added on
September 09, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive office and zip code)
(Registrant’s telephone number, including area code)
(Not applicable)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of Exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 | Regulation FD Disclosure | ||||
On September 9, 2026, Flotek Industries, Inc. (the “Company”) issued a press release providing updates to its previously disclosed guidance estimates for 2026. The press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
On September 9, 2026, the Company provided on its website an updated corporate presentation to be used in discussions at the Lake Street Annual Investor Conference to be held on September 10, 2026. A copy of the presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
The information furnished pursuant to Item 7.01 of this Current Report on 8-K and in Exhibit 99.1 and Exhibit 99.2 shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), is not subject to the liabilities of that section and is not deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
Item 9.01 | Financial Statements and Exhibits. | ||||
d) Exhibits.
| Exhibit Number | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FLOTEK INDUSTRIES, INC. | ||||||||
Date: September 9, 2026 | /s/ Bond Clement | |||||||
| Name: | Bond Clement | |||||||
| Title: | Chief Financial Officer | |||||||
Exhibit 99.1
Flotek Raises 2026 Guidance Again on
Continued Strength of International Sales
HOUSTON, September 9, 2026 — Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) today announced an increase to its previously disclosed guidance estimates for 2026 total revenue and Adjusted EBITDA.
Following strong second-quarter results, on August 4, 2026, the Company raised its full-year 2026 guidance for total revenue to a range of $340 million to $350 million and for Adjusted EBITDA(1) to a range of $47 million to $51 million. As a result of the current outlook for international chemistry sales in the second half of 2026, the Company expects 2026 total revenue of $360 million to $370 million and Adjusted EBITDA(1) of $50 million to $54 million. At the midpoints of the increased 2026 guidance ranges, total revenue and Adjusted EBITDA would represent growth of 54% and 58%, respectively, compared with the reported full-year 2025 metrics(2).
Chief Executive Officer Dr. Ryan Ezell said, "We have continued to experience growing demand, in particular in international chemistry, since increasing our 2026 guidance last month, giving us the confidence to further increase our outlook for the year. Our momentum through 2026 reflects sustained demand for Flotek's real-time data and chemistry technologies, strong customer response to our innovative solutions, and the continued execution of our corporate strategy.”
“International chemistry revenue was approximately $10.6 million in the second quarter of 2026, representing a more than 450% sequential increase from the first quarter. Supported by ongoing work in Saudi Arabia, we anticipate that international chemistry sales during the second half of 2026 could exceed $40 million. This growth, coupled with the expanding contribution from our Data Analytics segment, underscores our commitment to building a diversified and balanced platform. We believe these initiatives position Flotek for sustainable growth and continued shareholder value creation.”
(1)We are unable to reconcile our forward-looking Adjusted EBITDA guidance, a non-GAAP financial measure, to the most directly comparable GAAP financial measure, net income (loss), without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs and interest costs related to fluctuations in borrowings under the Company’s asset-based loan. These items do not impact the non-GAAP financial measure and could be material to future net income (loss). Guidance does not add back non-cash amortization of contract assets estimated to total approximately $9 million during full-year 2026. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information about these measures.
(2)See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information about these measures, including a reconciliation of Adjusted EBITDA, a non-GAAP measure, to the most directly comparable GAAP financial measure, net income (loss) for the year ended December 31, 2025.
1
Upcoming Investor Events
Flotek will participate in the Lake Street Annual Investor Conference to be held at the Metropolitan Club in New York, NY, September 10th, 2026. Flotek Chief Executive Officer Ryan Ezell will be hosting investor meetings during the event. An updated corporate presentation to be used in discussions at the conference will be posted to the Investor Relations section of Flotek’s corporate website at www.flotekind.com prior to the start of the conference.
Some other upcoming events in which we plan to participate:
•November 5th, 2026: INVEST: Houston Leadership Summit (Houston, TX)
•December 3rd, 2026: DEP Executive Series NASDAQ (New York, NY)
•December 9th-11th, 2026: ROTH Deer Valley (Park City, UT)
For the latest event details visit our Investor Relations page at https://ir.flotekind.com/events
About Flotek Industries, Inc.
Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company’s technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, over 20 years of field and laboratory data, and a global presence in more than 59 countries.
Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.
Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol “FTK.” For additional information, please visit www.flotekind.com.
Forward-Looking Statements
Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). These statements include, without limitation, statements regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects, including the Company's financial guidance, including forecasted revenue and Adjusted EBITDA ranges and forecasted international chemistry revenues. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and
2
uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Risks beyond the Company’s control, including ongoing and potential military conflicts in the Middle East and related logistics and supply chain disruptions, increased costs and security risks that could affect the Company’s ability to deliver products to the region, may cause actual results to differ materially from anticipated results. Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the “Risk Factors” section thereof), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.
Investor contact:
Mike Critelli
Vice President, Commercial & Investor Relations
3
FLOTEK INDUSTRIES, INC.
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands)
| Year Ended December 31, 2025 | ||||||||
| Net income | $ 30,528 | |||||||
| Interest expense | 3,937 | |||||||
| Income tax benefit | (10,873) | |||||||
| Depreciation and amortization | 1,836 | |||||||
EBITDA (Non-GAAP) (1) | $ 25,428 | |||||||
| Stock compensation expense | 2,300 | |||||||
| Severance and retirement | 575 | |||||||
| Contingent liability revaluation | (127) | |||||||
| Gain on disposal of asset | (7) | |||||||
Non-Recurring professional fees (2) | 4,621 | |||||||
Adjusted EBITDA (Non-GAAP) (1) | $ 32,790 | |||||||
(1)Management believes that EBITDA and Adjusted EBITDA for the year ended December 31, 2025 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company’s normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. Adjusted EBITDA as presented above does not add back non-cash amortization of contract assets totaling $6.3 million.
(2)Includes $4.4 million of expenses related to an asset acquisition.
4
September 10, 2026 Lake Street Annual Investor Growth Conference
Forward-Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. These statements include, without limitation, statements regarding the Company’s financial guidance, including forecasted revenue and Adjusted EBITDA ranges and forecasted international chemistry revenue, expected revenues under the Company’s long-term contracts, the total term of such contracts, the timing of the scaling and deployment of equipment, the total power capacity and operating performance of equipment once deployed, and the Company’s ability to perform under and satisfy the terms and conditions of its contracts. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this presentation. Although forward-looking statements in this presentation reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks related to the Company’s projects that are outside the Company's control, including, without limitation, securing fuel supply, international logistics, supply chain disruptions, obtaining permits and governmental approvals, satisfying financial requirements, third-party equipment delivery, construction execution and scheduling, meeting execution deadlines, integrating systems, political and regulatory developments, actions taken by governmental or regulatory authorities, disputes among project participants, the outcome of any investigations or legal proceedings, geopolitical instability or armed conflicts, and severe weather events. Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K and Form 10-Q (including, without limitation, in the "Risk Factors" section thereof), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this presentation. This presentation includes certain non-GAAP measures. Please refer to the reconciliations provided in the earnings press release and the appendix in this presentation for the most comparable GAAP measure. // 2
74% 26% 2Q25 49%51% 2Q26 Transformation to Data-Driven Growth // 3 THE CONVERGENCE OF REAL-TIME DATA AND CHEMISTRY SOLUTIONS Transforming business through real-time data, monitoring and process control across the energy & infrastructure value chain utilizing proprietary technologies Data Analytics Sustainable chemistry solutions to maximize customer’s value chain while minimizing their environmental impact Chemistry Technologies FLOTEK INDUSTRIES PROFILE: Founded: 1985 Employees: 160 Headquarters: Houston Patents: >130 Segment Gross Profit Contribution: $23.8MM$14.4MM
// 4 COMPLETION CHEMISTRY FRAC POWER GENERATION TRANSMIX MONITORING TREATMENT/STABILIZATION FLARE MONITORING DATA CENTER POWER GRID POWER TERMINAL & STORAGE MONITORING LNG TERMINALING AND EXPORTATION WATER TREATMENT ACID TREATMENT CEMENTING ADDITIVES THE CONVERGENCE OF INNOVATIVE DATA AND CHEMISTRY SOLUTIONS Flotek: Expanding Addressable Market
2Q26 2Q25 % Change Revenue $ 99.4 $ 58.4 70% Gross Profit $ 23.8 $ 14.4 65% Net Income $ 10.0 $ 1.8 463% Adj. EBITDA* $ 16.8 $ 8.0 109% Diluted EPS $ 0.26 $ 0.05 420% • Strongest quarter in the last 10 years as revenue approached $100 million, up 70% from year-ago • Data Analytics achieved its highest-ever quarterly revenue shattering 1Q26 record by 85% • Q2 International Chemistry revenue of $10.6 million represents 94% of full-year 2025 International Chemistry revenue • Net Income and Adj. EBITDA* increased 463% and 109%, respectively, from year-ago quarter • Raised Annual Revenue and Adj. EBITDA Guidance for the 2nd time on 9/9/2026 Flotek Q2 2026 Highlights // 5 *Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure. Calculations above do not add back non-cash amortization of contract assets totaling $2.4 million and $1.4 million during the second quarters of 2026 and 2025, respectively. In $MM GROWTH TRAJECTORY ACCELERATING IN 2026
-$30 -$4 $15 $33 -5% 13% 21% 25% -7% -2% 3% 8% 13% 18% 23% 28% -$30 -$20 -$10 $0 $10 $20 $30 $40 $50 $60 2022 2023 2024 2025 2026** G ro ss M a rg in A d j. E B IT D A * ($ M M ) Gross Margin // 6 Transformational Growth Storyline Continues RECENTLY RAISED GUIDANCE REFLECTS STRONG GROWTH METRICS VS 2025 *Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure. Calculations above do not add back non-cash amortization of contract assets totaling $3.4 million, $5 million, $5.6 million, and $6.3 million during the years ended December 31, 2022, 2023, 2024 and 2025, respectively. ** A non-GAAP measure. See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” tables in the appendix for more information about this measure. We are unable to reconcile this forward-looking non-GAAP measure to the most directly comparable GAAP measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP measure, including, among other items, certain stock-based compensation costs and interest costs related to fluctuations in borrowings outstanding under the Company’s asset based loan. These items do not impact the non-GAAP measure. Guidance does not add back expected non-cash amortization of contract assets totaling approx $9 million during 2026. $50-54 Metric Previous Guidance Range New Guidance Range New Midpoint Vs. 2025 Revenue: $340MM - $350MM $360MM - $370MM +54% Adj. EBITDA**: $47MM - $51MM $50MM - $54MM +58% FY 2026 UPDATED GUIDANCE As of 9/9/2026, this marks the second increase to guidance in the current year.
Chemistry Technologies: Market Growth // 7 • Strongest quarter of chemistry sales since 2017 • Domestic Chemistry revenue up 43% from 2Q25 • International Chemistry revenue totaled $10.6MM, up 172% from a year ago • International Chemistry revenue expected to surpass $40 million in 2H26 ($12.6 million 1H26) • Convergence of Real-time Data and Chemistry to emerge as growth opportunity REVENUE GROWTH IN A CONTRACTING MARKET *Chemistry Revenue excludes Related Party order shortfall payment “OSP” **Fleet Count numbers sourced from Primary Vision $22.2 $47.8 $22.5 $31.1 192 182 150 155 160 165 170 175 180 185 190 195 200 $- $10.0 $20.0 $30.0 $40.0 $50.0 $60.0 $70.0 $80.0 $90.0 2Q25 2Q26 Total Chemistry Revenue* Related Party Revenue* External Chem. Revenue Avg. Frac Fleet Count** $MM $78.9 $44.7
Chemistry Technologies: International Growth // 8 • 2H26 revenues expected to surpass $40 million vs $12.6 million 1H26 • The primary fluid chemistry supplier supporting unconventional operations in Saudi Arabia • Establishing an extended supply operation to support activity throughout mid-2027 INTERNATIONAL SALES EXPECTED TO EXPAND +200% in 2H26 vs 1H26 $3.9 $10.6 $- $2.0 $4.0 $6.0 $8.0 $10.0 $12.0 2Q25 2Q26 International Revenue $MM
73% 27% 2Q 2026 % of Service Revenue* % of Product Revenue 2Q26 EXTERNAL REVENUE EXCEEDED TOTAL SEGMENT REVENUE IN YEAR-AGO QUARTER 2Q26 revenue from Montana Power Services Contract totaled $5.9 million driving year-over-year growth // 9 *Service revenues include rental related revenues Revenue Mix Data Analytics: Rapid and Scalable Growth $3.3 $7.1 $2.6 $12.1 $- $2.0 $4.0 $6.0 $8.0 $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 2Q25 2Q26 Data Analytics Revenue Related Party Revenue External Revenue $19.2 $5.9 $MM
Power Services Gas Monitoring & Conditioning Measurement Control & Condition Distribution ✓ Real-Time Gas Measurement • BTU • CH4 • H2S • Volume • Temperature ✓ Custody Transfer Usage Report ✓ Optimizing Engine Performance ✓ Real-Time Gas Conditioning, Blending & Substitution ✓ Real-time Digital Engine Control ✓ Emergency Shutoff Protection ✓ Liquids Separation ✓ Engine Protection from Contaminants ✓ Pressure Control for Optimal Turbine and/or Recip. Performance ✓ Temperature Control ✓ Optimized Load Balancing and Volume ✓ Digital Platform Integration with Most Relevant Customer Technologies ACTIVE ON +50% OF DOMESTIC NATURAL GAS FLEETS BY YEAR END // 10
Case Study: Real-Time Field Gas Blending PWRTEK’S REAL-TIME MEASUREMENT AND BLENDING FIELD GAS SYSTEM VALUE STREAM ANNUAL IMPACT WHAT IT DELIVERS Fuel Cost Elimination $1.3M – $1.7M Switch from purchased pipeline gas/diesel to near-zero marginal cost field gas Maintenance Cycle Extension $0.6M – $1.6M Fewer knock events, stable combustion, longer overhaul intervals, less downtime Power & Efficiency Recovery $1.0M – $1.7M Higher output, reduced derating, optimized performance Emissions & ESG Value $0.2M – $0.5M Lower emissions and operator regulatory compliance credits TOTAL $3.1M – $5.5M 6x -10x CUSTOMER ROI Customer Challenge Large OFS Power producer was struggling with uptime and equipment failures when using field gas. Field gas often has extreme variability and contaminants that cause engine knock, derates, and downtime on conventional systems. Our Approach PWRtek’s real-time measurement technology, closed-loop blending and PID control can maintain optimal engine fuel quality for customers. This provides customers with safe real-time dynamic substitution of variable field gas while integrating with clients CNG for on-site power generation. Client Results During a severe gas quality disturbance, the platform-maintained target Methane Number (~66.3) with zero engine events and achieved >92% field gas substitution. It delivered $3.1M–$5.5M in annual value per 40 MW spread through fuel cost savings, efficiency gains, reduced maintenance, and ESG monetization. Client accomplished zero down-time over 14 days. // 11 OUTPUT FUEL (MN) BLENDING VALVE POSTION
The Power of Data & Chemistry in Action MAXIMIZE CRUDE DIGITAL VALUATION WHILE REMOVING THE MYSTERY // 12 CHEMISTRY Friction Reducers Guar Surfactant Clay/Iron Control Water Quality Acid % PROPPANT Sand / Ceramic proppant systems for fracture conductivity ENGINEERING Frac Rate, pressure & fluid design optimization TIER 2 GEOLOGY Formation characterization & targeting UNLEASH THE FLO Real-time Well Production Oil Composition Making Tier 1 Economics on Tier 2 Geology Measurable
Fingerprinting the Well with Real-Time Data PCM TEAM IS PRESCRIBING HIGH ROI CHEMICALS FOR EACH OPERATOR’S GOAL // 13 ✓ Higher Resolution of Crude (API Gravity, RVP, & C1-C6+) ✓ Operator Ability to Test all the Components of a Completion ✓ Viper Platform Analytics Across All Measurement Technologies ✓ 1-6% Volume Uplift When Combined with PCMTM
Data Analytics: Digital Valuation // 14 • 89 digital valuation units currently deployed or on order to be delivered vs 25 active units at the end of 2025 • Digital Valuation has more than 200,000 potential locations* in the US alone • In 2025, the XSPCTTM analyzer was introduced for custody transfer and/or digital valuation (Gas & Crude Quality) • In Nov 2025, the XSPCTTM was the first optical spectrometer to successfully achieve the GPA 2172 standard XSPCTTM CONTINUES TO EXPAND DATA ANALYTICS DAAS REVENUE XSPCT Analyzer Measuring Crude Quality Production in the Permian Basin * According to U.S. Energy Information Administration there are approximately 918,481 active O&G wells in the United States
$2.50 $7.50 $12.50 $17.50 $22.50 $27.50 $32.50 $37.50 $42.50 // 15 Flotek Industries AN INDUSTRIALIZED PIVOT TO DATA DRIVEN GROWTH Flotek: Turnaround Story • Leadership: New Executive Team 2023: Common Stock +533%* through Sep 4th ‘26 • Growing Profits: 2Q26 YoY net income increased 463% • Proven Momentum: 3 Straight Years of Adjusted EBITDA** Growth The Convergence of Real-time Data & Chemistry • Cycle-Resistant Revenue: Long-term contracts shield against O&G volatility • Differentiated Tech: Innovative Data and Chemistry solutions deliver superior value • Market Opportunities: Expanded and Diversified Addressable Market Proprietary Tech Fuels Recurring, High-Margin Growth • PWRtek TM : Continues to perform well with its differentiated technology • XSPCT TM : 2026 Winner of Product of the Year at Analyzer Tech Conference • VeraCal TM : Top OOOOb EPA-certified flare monitoring solution *New CEO Announced: June 6, 2023 closing stock price: $3.72 compared to September 4, 2026 closing stock price: $23.54 **Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure. ***A non-GAAP measure. See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” tables in the appendix for more information about this measure. We are unable to reconcile this forward-looking non-GAAP measure to the most directly comparable GAAP measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP measure, including, among other items, certain stock-based compensation costs and interest costs related to fluctuations in borrowings outstanding under the Company’s asset based loan. These items do not impact the non-GAAP measure. $52 million reflects the mid-point of 2026 guidance as shown on slide 6 and does not add back expected non-cash amortization of contract assets totaling approx $9 million. 2023 2024 2025 533% 2026 $mm 2025 2026 Md Pt Revenue $237 $365*** Net Income Adj EBITDA** $30.5 $32.8 N/A*** $52*** $mm 12/31/25 6/30/26 Net Debt $37 $45.5 Leverage Ratio 1.1X 0.9X (a) Market Cap $519 $846 (a) using mid-point 2026 guidance Flotek Industries (FTK) Industry: Energy & Technology
// 16 INVEST: Houston 3rd Edition Leadership Summit November 5th JW Marriott Houston, TX DEP Permian BBQ November 10-11th 2026 Scharbauer Sports Complex Midland, TX Roth Deer Valley December 9th-12th 2026 Park City, UT DEP NY Executive Series December 3rd 2026 Nasdaq MarketSite New York, NY Investor Contact: Mike Critelli [email protected] Upcoming 2026 Events JOIN US
Appendix
// 18 • Prescriptive Chemistry Management (PCM)TM – Proprietary energy chemistry solutions – Experienced chemistry energy team – Customized solutions to each well’s geology • AI Driven Analytics from >20,000 wells • 10+ Years with no HSE recordable incidents • Real-Time Field Data to Enhance Performance • Field Correlated Diagnostics • +130 Patents DELIVERING TOP TIER WELL PERFORMANCE IN INDUSTRY Chemistry Technologies: Competitive Advantage
Data Analytics: “Measure More Strategy” Upstream • Power Services: facilitates natural gas utilization in powering turbines and dual-fuel engines • Digital Valuation: delivers real-time product valuations for faster & more accurate Custody Transfer reporting • Flare Monitoring: assisting in the compliance of EPA regulations and enhanced flare efficiency control Midstream • Gas/Oil processing plant control and optimization • TransMix Pipeline batch detection to optimize pipeline transfer processes • Vapor Pressure Monitoring controls to achieve product specifications Downstream • Process Controls: to optimize distillation tower efficiency • Chemical Quality Measurements in pipelines and terminals • Carbon Capture measurement for carbon credits and reporting REAL-TIME MEASUREMENTS FOR EXPANSION INTO NEW MARKETS // 19 Growth
Customer Challenge An upstream operator needed clearer insight into how premium frac chemistries affected crude quality and production. Our Approach Flotek installed XSPCT analyzers and delivered continuous crude quality data while tracking crude quality and chemistry data via our Viper platform. Client Results Within 60 days, the operator identified: • Superior chemistries • 1–6% production volume improvement • Applied to additional West Texas pads • Higher ROI on completion + lower LOE Convergence of Data & Chemistry IMPROVING CHEMISTRY EFFECTIVENESS AND FIELD PERFORMANCE WITH REAL TIME DATA // 20 ✓ Higher Resolution of Crude Quality Insight ✓ Identified Best Completion Chemistry ✓ Expected 1-6% Volume Uplift
Power Services Technology // 21 PATENTED TECHNOLOGY ENABLES SCALABLE, LOW COST, GRID-FREE ENERGY, & ENGINE PROTECTION City Gas CNG Field Gas Waste/Biogas Measure Control Distribute Reciprocating Engine Gas Turbine Engine Control Module BTU CH4 Number HHV LHV Wobbe Index H2S and CO2 Volume Density ESD Protection Liquids Separation Blending Scrubbing Durability Efficiency Smaller Footprint Emissions Pressure Temperature Plug N Play Redundancy Optimize Volume Diesel (Blending Substitute) Alternative Fuel Source Incumbent Fuel Source
Data Analytics: Power Services Contract // 22 FIRST INFRASTRUCTURE & UTILITIES POWER CONTRACT IN MONTANA Key Contract Terms: • Up to 50 MW deployment for federal disaster recovery • 6-month initial term with customer option to extend • Proprietary PWRtekTM reduces risks from variable gas quality in harsh conditions Progress Update: Phase 1- (12 MW total) • 2Q 2026 revenue totaled $5.9MM • Initial power generation paused due to infrastructure delays • Currently in discussions on Phase 2 extension Phase 2 Extension Deployment Power Load Assessment Site Visits & Selection Contract Award Proposal
We tested against Traditional Gas Chromatography (GC) • Zero GC Samples matched the 60-day Average Gas BTU Value • 20-25% swings in “Associated Gas” BTU value • 16% Variances within manual sampling processes • Missed High Value Liquids on “dry gas” wells Data Analytics: Digital Valuation Solution // 23 INITIAL PENETRATION INTO SIGNIFICANT UPSTREAM APPLICATIONS No Shelter, No Calibration Gas, Remotely/Continuously Monitored San Antonio Houston Example: 60 days of real-time BTU Values; demonstrates extreme variability. GC Spot Sample Lab Test $4.4MM* ANNUAL PROCEEDS IMPACT PER UNIT *$2.50 $/MMbtu @ 15mmscf/D
// 24 Recent Financials Unaudited Condensed Consolidated Balance Sheets (in thousands, except per share data)
Recent Financials Unaudited Condensed Consolidated Statements of Operations (in thousands, except per share data) // 25
// 26 Recent Financials Unaudited Condensed Consolidated Statements of Cash Flows (in thousands)
// 27 1) Management believes that EBITDA and Adjusted EBITDA for the three and six months ended June 30, 2026 and 2025 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company’s normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. Adjusted EBITDA as presented above does not add back non-cash amortization of contract assets totaling $2.4 million and $1.4 million during the three months ended June 30, 2026 and 2025, respectively, and $4.7 million and $2.9 million during the six months ended June 30, 2026 and 2025, respectively. 2) Includes $4.2 million of expenses for the three and six months ended June 30, 2025 related to an asset acquisition. Recent Financials Unaudited Reconciliation of Non-GAAP Items & Non-Cash Items Impacting Earnings (in thousands)(1)
// 28 1) Management believes that EBITDA and Adjusted EBITDA for the twelve months ended December 31, 2022, 2023, 2024 and 2025 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company’s normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. Adjusted EBITDA as presented above does not add back non-cash amortization of contract assets totaling $3.4 million, $5.0 million, $5.6 million and $6.3 million for the years ended December 31, 2022, 2023, 2024 and 2025, respectively. 2) Includes $4.4 million of expenses related to an asset acquisition for the twelve months ended December 31, 2025. Recent Financials Unaudited Reconciliation of Non-GAAP Items & Non-Cash Items Impacting Earnings (in thousands)(1)